Immunization of Aotus Monkeys with Recombinant Plasmodium falciparum Hybrid Proteins Does Not Reproducibly Result in Protection from Malaria Infection
AUTOR(ES)
Kocken, Clemens H. M.
FONTE
American Society for Microbiology
RESUMO
Plasmodium falciparum antigens SERP, HRPII, MSAI, and 41-3 have shown promise as vaccine components. This study aimed at reproducing and extending previous results using three hybrid molecules. Antibody responses were reproduced in Aotus monkeys, but solid protection from a P. falciparum blood-stage challenge that showed an unintendedly enhanced pathogenicity was not observed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=107908Documentos Relacionados
- Protection of Aotus monkeys from malaria infection by immunization with recombinant hybrid proteins.
- Immunization of Aotus monkeys with Plasmodium falciparum blood-stage recombinant proteins.
- Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface protein 1 in liposomes and alum adjuvant does not induce protection against a challenge infection.
- Protective immunity induced in Aotus monkeys by recombinant SERA proteins of Plasmodium falciparum.
- Immunization of Aotus monkeys with a functional domain of the Plasmodium falciparum variant antigen induces protection against a lethal parasite line